Analysis of WLYB Dividend Predictions and Stock Performance
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Apr 06 2026
0mins
Source: NASDAQ.COM
- Dividend Yield Expectation: WLYB's current estimated annualized dividend yield stands at 3.70%, and its sustainability should be assessed against historical data to gauge future dividend reliability.
- Price Fluctuation Range: The stock's 52-week low is $29.16 and high is $45.41, with the latest trade at $38.43, indicating significant price movement within this range.
- Market Performance Analysis: On Monday, shares of John Wiley & Sons Inc. fell approximately 1.7%, reflecting a negative short-term sentiment in the market towards the stock.
- Technical Indicator Reference: Comparing the stock's performance against the 200-day moving average provides a clearer understanding of WLYB's price behavior, aiding investors in making more informed investment decisions.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy WLYB?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on WLYB
Wall Street analysts forecast WLYB stock price to rise
0 Analyst Rating
0 Buy
0 Hold
0 Sell
Current: 43.225
Low
Averages
High
Current: 43.225
Low
Averages
High
No data
About WLYB
John Wiley & Sons, Inc., is a publisher. The Company's content, services, platforms, and knowledge networks are tailored to meet the needs of its customers and partners, including researchers, students, instructors, professionals, institutions, and corporations. Its segments include Research, Learning and Held for Sale or Sold. Research segment provides peer-reviewed scientific, technical, and medical (STM) publishing, content platforms, and related services to academic, corporate, and government customers, academic societies, and individual researchers. Its journal publishing categories include the social sciences and humanities, and life sciences. Learning segment provides scientific, professional, and education print and digital books, digital courseware to libraries, corporations, students, professionals, and researchers, as well as assessment services to businesses and professionals. Its operations are located in the United States, United Kingdom, India, Sri Lanka, and Germany.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
John Wiley & Sons Reports Strong Cash Flow and AI Growth
- AI Revenue Growth: John Wiley & Sons saw its AI revenue increase from $40 million to $49 million, demonstrating the company's leadership in the AI economy, with expectations for continued acceleration that will drive a transformation in overall revenue structure.
- Significant Free Cash Flow Increase: Free cash flow surged by 55% to $195 million, reflecting the company's success in operational efficiency and cost control, which enhances its capital allocation capabilities and potential for shareholder returns.
- Strategic Importance of Emerald Acquisition: The $450 million acquisition of Emerald Publishing is expected to positively impact earnings per share in the first year, further strengthening the company's market share and content advantage, particularly in finance and economics.
- Adjusted EBITDA Margin Improvement: The adjusted EBITDA margin improved by 220 basis points to 26.2%, indicating ongoing enhancements in cost management and operational efficiency, which will help boost future profitability and investor confidence.
See More
John Wiley & Sons Q4 Earnings Beat Expectations
- Earnings Beat: John Wiley & Sons reported a Q4 Non-GAAP EPS of $1.67, exceeding expectations by $0.02, indicating stable profitability amidst market challenges.
- Revenue Miss: The company generated $447.94 million in revenue for Q4, a 1.2% year-over-year increase, yet fell short of expectations by $2.06 million, highlighting competitive pressures affecting growth.
- Cash Flow Improvement: Operating cash flow reached $261 million, up 29%, while free cash flow surged to $195 million, a 55% increase, demonstrating significant advancements in cash management and operational efficiency.
- Positive Outlook: For fiscal 2027, the company projects adjusted EPS between $4.60 and $5.05, with adjusted EBITDA margins expected to rise to 26.5% to 27.5%, reflecting confidence in future growth prospects.
See More
Wiley Reports Strong Fiscal 2026 Results with Record EPS and Cash Flow
- Revenue and Profit Growth: Wiley reported fiscal 2026 revenue of $1.677 billion, flat year-over-year, but operating income surged to $277 million, a 25% increase, indicating strong performance in the research sector.
- Adjusted EPS Increase: Adjusted earnings per share (EPS) rose 15% to $4.19, reflecting ongoing investments and growth in research and AI, enhancing shareholder return potential.
- Sustained Cash Flow Growth: Operating cash flow reached $261 million, up 29% year-over-year, while free cash flow increased by 55% to $195 million, demonstrating significant improvements in capital management and profitability.
- Strategic Acquisition and Leadership Changes: Wiley acquired Emerald Publishing to bolster its scale and content advantage in research, while appointing a new Chief AI and Data Analytics Officer to further drive commercialization in AI and data analytics.
See More
Wiley and IQVIA Release AI and Science Report
- Executive Summit Insights: The executive summit co-hosted by Wiley and IQVIA brought together over 25 senior leaders from pharma, academia, and technology to discuss the role of AI in the science-to-patient journey, highlighting the need for cross-sector collaboration.
- Gap Between AI and Health Systems: The report emphasizes that while AI accelerates every stage from scientific discovery to patient benefit, a significant gap exists between AI's technical capabilities and the health system's ability to absorb these advancements, necessitating structural changes.
- Five High-Potential Directions: Participants identified five high-potential directions, including decision-first discovery, sharing structured negative data, and deploying patient-facing AI agents, aimed at enhancing the integration of scientific research and clinical application.
- Challenges of Incentive Structures: The report candidly addresses that existing incentive structures hinder optimization for science, patients, and long-term progress, underscoring the need for collaboration across sectors to achieve necessary structural changes.
See More
Wiley to Release Q4 and FY 2026 Results on June 16, 2026
- Earnings Release Schedule: Wiley will release its fourth quarter and fiscal year 2026 results before the market opens on June 16, 2026, highlighting the company's ongoing leadership in scientific discovery and innovation.
- Conference Call Timing: The company has scheduled a conference call at 10 AM ET on the same day to discuss the results, which is expected to attract significant attention from investors and analysts alike.
- Investor Relations Link: Investors can access real-time information through the company's investor relations page or directly via the specified webcast link, enhancing transparency and communication efficiency.
- Global Influence: With over 200 years of publishing heritage, Wiley combines trusted academic traditions with AI-powered platforms to transform scientific breakthroughs into real-world impact, further solidifying its central role in the global scholarly ecosystem.
See More
Wiley Acquires Emerald Publishing for £337 Million
- Transaction Scale and Impact: Wiley has acquired Emerald Publishing for £337 million (approximately $452 million), with a valuation around 7x Adjusted EBITDA, expected to positively impact Adjusted EPS in the first year.
- Journal Portfolio Expansion: This acquisition expands Wiley's journal portfolio to approximately 2,500 titles, solidifying its leadership in social sciences, particularly in economics, business, and finance, thereby enhancing its competitive edge in the academic publishing market.
- Revenue and Synergies: Emerald is projected to generate over $85 million in revenue in fiscal year 2026, with 92% recurring subscription revenue, while Wiley anticipates realizing approximately $30 million in annual run-rate cost synergies by year three, further enhancing profitability.
- Strategic Fit and Future Outlook: The cultural and business compatibility between Wiley and Emerald strengthens Wiley's content advantage in AI and data analytics, enhancing its influence in the global research community and aligning with both companies' long-term growth strategies.
See More
John Wiley & Sons Reports Strong Cash Flow and AI Growth
- AI Revenue Growth: John Wiley & Sons saw its AI revenue increase from $40 million to $49 million, demonstrating the company's leadership in the AI economy, with expectations for continued acceleration that will drive a transformation in overall revenue structure.
- Significant Free Cash Flow Increase: Free cash flow surged by 55% to $195 million, reflecting the company's success in operational efficiency and cost control, which enhances its capital allocation capabilities and potential for shareholder returns.
- Strategic Importance of Emerald Acquisition: The $450 million acquisition of Emerald Publishing is expected to positively impact earnings per share in the first year, further strengthening the company's market share and content advantage, particularly in finance and economics.
- Adjusted EBITDA Margin Improvement: The adjusted EBITDA margin improved by 220 basis points to 26.2%, indicating ongoing enhancements in cost management and operational efficiency, which will help boost future profitability and investor confidence.
See More
John Wiley & Sons Q4 Earnings Beat Expectations
- Earnings Beat: John Wiley & Sons reported a Q4 Non-GAAP EPS of $1.67, exceeding expectations by $0.02, indicating stable profitability amidst market challenges.
- Revenue Miss: The company generated $447.94 million in revenue for Q4, a 1.2% year-over-year increase, yet fell short of expectations by $2.06 million, highlighting competitive pressures affecting growth.
- Cash Flow Improvement: Operating cash flow reached $261 million, up 29%, while free cash flow surged to $195 million, a 55% increase, demonstrating significant advancements in cash management and operational efficiency.
- Positive Outlook: For fiscal 2027, the company projects adjusted EPS between $4.60 and $5.05, with adjusted EBITDA margins expected to rise to 26.5% to 27.5%, reflecting confidence in future growth prospects.
See More
Wiley Reports Strong Fiscal 2026 Results with Record EPS and Cash Flow
- Revenue and Profit Growth: Wiley reported fiscal 2026 revenue of $1.677 billion, flat year-over-year, but operating income surged to $277 million, a 25% increase, indicating strong performance in the research sector.
- Adjusted EPS Increase: Adjusted earnings per share (EPS) rose 15% to $4.19, reflecting ongoing investments and growth in research and AI, enhancing shareholder return potential.
- Sustained Cash Flow Growth: Operating cash flow reached $261 million, up 29% year-over-year, while free cash flow increased by 55% to $195 million, demonstrating significant improvements in capital management and profitability.
- Strategic Acquisition and Leadership Changes: Wiley acquired Emerald Publishing to bolster its scale and content advantage in research, while appointing a new Chief AI and Data Analytics Officer to further drive commercialization in AI and data analytics.
See More
Wiley and IQVIA Release AI and Science Report
- Executive Summit Insights: The executive summit co-hosted by Wiley and IQVIA brought together over 25 senior leaders from pharma, academia, and technology to discuss the role of AI in the science-to-patient journey, highlighting the need for cross-sector collaboration.
- Gap Between AI and Health Systems: The report emphasizes that while AI accelerates every stage from scientific discovery to patient benefit, a significant gap exists between AI's technical capabilities and the health system's ability to absorb these advancements, necessitating structural changes.
- Five High-Potential Directions: Participants identified five high-potential directions, including decision-first discovery, sharing structured negative data, and deploying patient-facing AI agents, aimed at enhancing the integration of scientific research and clinical application.
- Challenges of Incentive Structures: The report candidly addresses that existing incentive structures hinder optimization for science, patients, and long-term progress, underscoring the need for collaboration across sectors to achieve necessary structural changes.
See More
Wiley to Release Q4 and FY 2026 Results on June 16, 2026
- Earnings Release Schedule: Wiley will release its fourth quarter and fiscal year 2026 results before the market opens on June 16, 2026, highlighting the company's ongoing leadership in scientific discovery and innovation.
- Conference Call Timing: The company has scheduled a conference call at 10 AM ET on the same day to discuss the results, which is expected to attract significant attention from investors and analysts alike.
- Investor Relations Link: Investors can access real-time information through the company's investor relations page or directly via the specified webcast link, enhancing transparency and communication efficiency.
- Global Influence: With over 200 years of publishing heritage, Wiley combines trusted academic traditions with AI-powered platforms to transform scientific breakthroughs into real-world impact, further solidifying its central role in the global scholarly ecosystem.
See More
Wiley Acquires Emerald Publishing for £337 Million
- Transaction Scale and Impact: Wiley has acquired Emerald Publishing for £337 million (approximately $452 million), with a valuation around 7x Adjusted EBITDA, expected to positively impact Adjusted EPS in the first year.
- Journal Portfolio Expansion: This acquisition expands Wiley's journal portfolio to approximately 2,500 titles, solidifying its leadership in social sciences, particularly in economics, business, and finance, thereby enhancing its competitive edge in the academic publishing market.
- Revenue and Synergies: Emerald is projected to generate over $85 million in revenue in fiscal year 2026, with 92% recurring subscription revenue, while Wiley anticipates realizing approximately $30 million in annual run-rate cost synergies by year three, further enhancing profitability.
- Strategic Fit and Future Outlook: The cultural and business compatibility between Wiley and Emerald strengthens Wiley's content advantage in AI and data analytics, enhancing its influence in the global research community and aligning with both companies' long-term growth strategies.
See More
